UN votes to ban therapeutic cloning - UK defiant:
This article was originally published in Clinica
The United Nations has approved the adoption of a Declaration under which member states would be called on to prohibit all forms of human cloning, including so-called "therapeutic cloning" for research purposes. On February 19, the UN's General Assembly voted 71-35 in favour, with 43 abstentions. The UK said it regretted the outcome, arguing that "states should reach their own national consensus on whether to permit or prohibit therapeutic cloning", given the potential medical benefits of the technology. It added that the Declaration is non-binding and would thus not affect the UK's approach to stem cell research, where "therapeutic cloning research would continue to be permitted".
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.